Impact of pre-existing SARS-CoV-2 reactive T cells in uninfected individuals on COVID-19 mortality in different countries
View ORCID ProfileGennadi V. Glinsky
doi: https://doi.org/10.1101/2020.10.03.20206151
Gennadi V. Glinsky
1Institute of Engineering in Medicine, University of California, San Diego, 9500 Gilman Dr. MC 0435, La Jolla, CA 92093-0435, USA
Article usage
Posted October 06, 2020.
Impact of pre-existing SARS-CoV-2 reactive T cells in uninfected individuals on COVID-19 mortality in different countries
Gennadi V. Glinsky
medRxiv 2020.10.03.20206151; doi: https://doi.org/10.1101/2020.10.03.20206151
Subject Area
Subject Areas
- Addiction Medicine (319)
- Allergy and Immunology (622)
- Anesthesia (162)
- Cardiovascular Medicine (2334)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11685)
- Forensic Medicine (10)
- Gastroenterology (691)
- Genetic and Genomic Medicine (3669)
- Geriatric Medicine (345)
- Health Economics (629)
- Health Informatics (2357)
- Health Policy (924)
- Hematology (339)
- HIV/AIDS (769)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (395)
- Neurology (3425)
- Nursing (193)
- Nutrition (518)
- Oncology (1798)
- Ophthalmology (531)
- Orthopedics (214)
- Otolaryngology (285)
- Pain Medicine (229)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1018)
- Primary Care Research (413)
- Public and Global Health (6077)
- Radiology and Imaging (1251)
- Respiratory Medicine (818)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)